on Moderna, Inc. (NASDAQ:MRNA)
Moderna to Participate in March 2025 Investor Conferences

Moderna, Inc. has announced its upcoming participation in two significant investor conferences scheduled for March 2025. The company will present at the TD Cowen 45th Annual Health Care Conference on March 5th at 9:10am ET and the Barclays 27th Annual Global Healthcare Conference on March 11th at 1:30pm ET.
Both presentations will be accessible to the public via live webcasts, available under the "Events and Presentations" section in the Investors area on Moderna's website. The webcasts will be archived for a minimum of 30 days for later viewing.
These appearances reflect Moderna's ongoing engagement with the investor community and provide an opportunity to share insights into their mRNA technology advancements. Moderna remains at the forefront of mRNA medicine, with a focus on developing innovative treatments and vaccines.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Moderna, Inc. news